J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-386, 2015.

B. Escudier, C. Porta, P. Bono, T. Powles, T. Eisen et al.,

U. Giorgi, O. Parikh, R. Hawkins, E. Sevin, S. Négrier et al., Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study, J Clin Oncol, vol.32, pp.1412-1418, 2014.

E. M. Posadas, S. Limvorasak, and R. A. Figlin, Targeted therapies for renal cell carcinoma, Nat Rev Nephrol, vol.13, pp.496-511, 2017.

K. Mehta, K. Patel, and R. A. Parikh, Immunotherapy in genitourinary malignancies, J Hematol Oncol, vol.24, issue.1, p.95, 2017.

V. Dormoy, S. Danilin, V. Lindner, L. Thomas, S. Rothhut et al., The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth, Mol Cancer, issue.8, p.123, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00663549

C. Sourbier, V. Lindner, H. Lang, A. Agouni, E. Schordan et al., The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy, Cancer Res, vol.66, pp.5130-5142, 2006.

V. Dormoy, C. Béraud, V. Lindner, L. Thomas, C. Coquard et al., LIMclass homeobox gene Lim1, a novel oncogene in human renal cell carcinoma, Oncogene, vol.30, pp.1753-1763, 2011.

J. D. Barnes, J. L. Crosby, C. M. Jones, C. V. Wright, and B. L. Hogan, Embryonic expression of

, Lim-1, the mouse homolog of Xenopus Xlim-1, suggests a role in lateral mesoderm differentiation and neurogenesis, Dev Biol, vol.161, pp.168-178, 1994.

N. A. Hukriede, T. E. Tsang, R. Habas, P. L. Khoo, K. Steiner et al., Conserved requirement of Lim1 function for cell movements during gastrulation, Dev Cell, vol.4, pp.83-94, 2003.

S. S. Cheah, K. M. Kwan, and R. R. Behringer, Requirement of LIM domains for LIM1 function in mouse head development, Genesis, vol.27, pp.12-21, 2000.

Y. Zhao, K. M. Kwan, C. M. Mailloux, W. K. Lee, A. Grinberg et al., LIMhomeodomain proteins Lhx1 and Lhx5, and their cofactor Ldb1, control Purkinje cell differentiation in the developing cerebellum, Proc Natl Acad Sci, vol.104, pp.13182-13186, 2007.

S. Ledig, S. Brucker, G. Barresi, J. Schomburg, K. Rall et al., Frame shift mutation of LHX1 is associated with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, Hum Reprod, vol.27, pp.2872-2875, 2012.

C. C. Huang, G. D. Orvis, K. M. Kwan, and R. R. Behringer, Lhx1 is required in Müllerian duct epithelium for uterine development, Dev Biol, vol.389, pp.124-136, 2014.

M. C. Cirio, Z. Hui, C. E. Haldin, C. C. Cosentino, C. Stuckenholz et al., Lhx1 is required for specification of the renal progenitor cell field, PLoS One, vol.6, 2011.

I. Costello, S. Nowotschin, X. Sun, A. W. Mould, A. K. Hadjantonakis et al.,

, Lhx1 functions together with Otx2, Foxa2, and Ldb1 to govern anterior mesendoderm, node, and midline development, Genes Dev, vol.29, pp.2108-2122, 2015.

L. Ye, J. Evans, and C. E. Gargett, Lim1/LIM1 is expressed in developing and adult mouse and human endometrium, Histochem Cell Biol, vol.137, pp.527-536, 2012.

A. Varis, M. Wolf, O. Monni, M. L. Vakkari, A. Kokkola et al., Targets of gene amplification and overexpression at 17q in gastric cancer, Cancer Res, vol.62, pp.2625-2629, 2002.

N. Sato, N. Fukushima, A. Maitra, H. Matsubayashi, C. J. Yeo et al., Discovery of novel targets for aberrant methylation in pancreatic carcinoma using highthroughput microarrays, Cancer Res, vol.63, pp.3735-3742, 2003.

W. G. Tong, W. G. Wierda, E. Lin, S. Q. Kuang, B. N. Bekele et al., Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact, Epigenetics, vol.5, pp.499-508, 2010.

B. Guertl, U. Senanayake, E. Nusshold, I. Leuschner, S. Mannweiler et al.,

, Lim1, an embryonal transcription factor, is absent in multicystic renal dysplasia, but reactivated in nephroblastomas, Pathobiology, vol.78, pp.210-219, 2011.

M. Mumert, A. Dubuc, X. Wu, P. A. Northcott, S. S. Chin et al., Functional genomics identifies drivers of medulloblastoma dissemination, Cancer Res, vol.72, pp.4944-4953, 2012.

L. S. Qu, J. F. Guo, Y. M. Liu, T. T. Xue, R. Y. Huang et al., Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study, Oncol Lett, vol.11, pp.624-632, 2016.

S. Mikami, M. Oya, R. Mizuno, T. Kosaka, M. Ishida et al., Recent advances in renal cell carcinoma from a pathological point of view, Pathol Int, vol.66, pp.481-490, 2016.

T. C. Lin, Y. P. Liu, Y. C. Chan, C. Y. Su, Y. F. Lin et al., Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis, J Pathol, vol.237, pp.50-61, 2015.

Y. W. Lin, L. M. Lee, W. J. Lee, C. Y. Chu, P. Tan et al., Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-?B DNA-binding activity, J Pineal Res, vol.60, pp.277-290, 2016.

Z. Zhao, H. Liu, J. Hou, T. Li, X. Du et al., Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway, Oncol Res, vol.25, pp.773-779, 2017.

S. Valastyan and R. A. Weinberg, Tumor metastasis: molecular insights and evolving paradigms, Cell, vol.147, pp.275-292, 2011.

V. Dormoy, D. Jacqmin, H. Lang, and T. Massfelder, From development to cancer: lessons from the kidney to uncover new therapeutic targets, Anticancer Res, vol.32, pp.3609-3617, 2012.

H. Li, D. Yue, J. Q. Jin, G. A. Woodard, B. Tolani et al., Gli promotes epithelialmesenchymal transition in human lung adenocarcinomas, Oncotarget, vol.7, pp.80415-80425, 2016.

B. Z. Stanton and L. F. Peng, Small-molecule modulators of the Sonic Hedgehog signaling pathway, Mol Biosyst, vol.6, pp.44-54, 2010.

C. Sourbier, S. Danilin, V. Lindner, J. Steger, S. Rothhut et al., Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy, Cancer Res, vol.67, pp.11668-11676, 2007.

A. T. Beksac, D. J. Paulucci, K. A. Blum, S. S. Yadav, J. P. Sfakianos et al.,

, Heterogeneity in renal cell carcinoma, Urol Oncol, vol.pii, pp.30216-30218, 2017.

Y. Xia, N. Yeddula, M. Leblanc, E. Ke, Y. Zhang et al., Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model, Nat Cell Biol, vol.14, pp.257-265, 2012.

B. V. Kallakury, S. Karikehalli, A. Haholu, C. E. Sheehan, N. Azumi et al., Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma, Clin Cancer Res, vol.7, pp.3113-3119, 2001.

D. E. Jeong, H. J. Song, S. Lim, S. J. Lee, J. E. Lim et al., Repurposing the antimalarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis, Oncotarget, vol.6, pp.33046-33064, 2015.

H. Ruan, H. Yang, H. Wei, X. W. Lou, N. Qiu et al., Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelialmesenchymal transition, Int J Oncol, vol.51, pp.336-346, 2017.

Y. Wang, D. Fu, J. Su, Y. Chen, C. Qi et al., C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells, Sci Rep, vol.7, p.999, 2017.

V. A. Yerokhin and V. M. Shabaev, Nuclear Recoil Effect in the Lamb Shift of Light Hydrogenlike Atoms, Phys Rev Lett, vol.115, p.233002, 2015.

L. Liu, Y. Li, S. Liu, Q. Duan, L. Chen et al., Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN, Tumour Biol, vol.39, p.1010428317711951, 2017.

J. K. Li, C. Chen, J. Y. Liu, J. Z. Shi, S. P. Liu et al., Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling, Mol Cancer, vol.16, p.111, 2017.

H. Yang, P. Huo, G. Hu, B. Wei, D. Kong et al., Identification of gene markers associated with metastasis in clear cell renal cell carcinoma, Oncol Lett, vol.13, pp.4755-4761, 2017.

J. Zhu, C. Liang, Y. Hua, C. Miao, J. Zhang et al., The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-? 1/Smad signaling in renal cell carcinoma, Oncotarget, 2017.

Y. Gao, H. Li, X. Ma, Y. Fan, D. Ni et al., KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1, Cancer Res, vol.77, pp.330-342, 2017.

G. Scelo, M. P. Purdue, K. M. Brown, M. Johansson, Z. Wang et al.,

, Genome-wide association study identifies multiple risk loci for renal cell carcinoma, Nat Commun, vol.8, p.15724, 2017.

P. Neuberg, I. Hamaidi, S. Danilin, M. Ripoll, V. Lindner et al., Polydiacetylenic nanofibers as new siRNA vehicles for in vitro and in vivo delivery, Nanoscale, vol.10, pp.1587-1590, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01715827

B. Delahunt, L. Egevad, H. Samaratunga, M. Varma, C. Verrill et al., UICC drops the ball in the 8th edition TNM staging of urological cancers, Histopathology, vol.71, pp.5-11, 2017.

C. Béraud, V. Dormoy, S. Danilin, V. Lindner, A. Béthry et al., Targeting FAK scaffold functions inhibits human renal cell carcinoma growth, Int J Cancer, vol.137, pp.1549-1559, 2015.

N. A. Franken, H. M. Rodermond, J. Stap, J. Haveman, and C. Van-bree, Clonogenic assay of cells in vitro, Nat Protoc, vol.1, pp.2315-2319, 2006.